News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333 Results
Type
Article (54)
Press Release (279)
Section
Business (103)
Deals (24)
Drug Development (119)
FDA (10)
Job Trends (8)
News (204)
Policy (25)
Tag
Academia (4)
Adcomms (1)
Alliances (18)
Approvals (10)
Bankruptcy (1)
Best Places to Work (7)
Clinical research (85)
Compensation (2)
COVID-19 (32)
Data (3)
Diagnostics (10)
Earnings (40)
Events (66)
Executive appointments (1)
FDA (11)
GLP-1 (2)
Government (12)
Healthcare (13)
Infectious disease (32)
Influenza (1)
IPO (12)
Layoffs (2)
Legal (2)
Medical device (6)
Medtech (6)
Mergers & acquisitions (12)
NextGen: Class of 2025 (2)
Northern California (19)
People (46)
Phase I (58)
Phase II (47)
Phase III (23)
Pipeline (1)
Preclinical (26)
Regulatory (14)
Research institute (3)
Startups (2)
United States (21)
Vaccines (10)
Date
Today (1)
Last 7 days (2)
Last 30 days (4)
Last 365 days (29)
2025 (7)
2024 (28)
2023 (25)
2022 (48)
2021 (59)
2020 (65)
2019 (19)
2018 (31)
2017 (8)
2016 (10)
2015 (15)
2014 (7)
2013 (3)
2011 (1)
2010 (2)
Location
Asia (14)
California (20)
Colorado (1)
Europe (20)
Northern California (19)
South America (1)
333 Results for "vaxart".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
March 12, 2025
·
5 min read
Press Releases
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
March 13, 2025
·
1 min read
Press Releases
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
January 28, 2025
·
6 min read
Press Releases
Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs
January 15, 2025
·
9 min read
Press Releases
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
March 6, 2025
·
8 min read
Biotech Bay
Vaxart Provides Business Update - June 17, 2024
Vaxart, Inc. provided business and cash runway updates as the Company continues to advance its oral pill vaccine platform.
June 17, 2024
·
8 min read
Drug Development
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
Vaxart, Inc. (Nasdaq: VXRT) today announced that it has completed the topline analysis for the Phase 1 clinical trial evaluating Vaxart’s oral pill bivalent norovirus vaccine candidate.
April 30, 2024
·
7 min read
Biotech Bay
Vaxart Announces $40 Million Underwritten Offering of Common Stock
Vaxart, Inc. announced an underwritten offering of 50,000,000 shares of its common stock at an offering price of $0.80 per share, which is a premium to the last closing price of $0.75 per share.
June 13, 2024
·
3 min read
Press Releases
Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial
January 14, 2025
·
6 min read
Business
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
Vaxart, Inc. (Nasdaq: VXRT) today announced its business update and financial results for the first quarter of 2024.
May 13, 2024
·
10 min read
1 of 34
Next
